{"id":"https://openalex.org/W46216662","doi":null,"title":"New drugs and combinations for malignant glioma.","display_name":"New drugs and combinations for malignant glioma.","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W46216662","mag":"46216662","pmid":"https://pubmed.ncbi.nlm.nih.gov/14732888"},"language":"en","primary_location":{"id":"pmid:14732888","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14732888","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Forum (Genoa, Italy)","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053052330","display_name":"Roger Stupp","orcid":"https://orcid.org/0000-0002-5483-3118","observed_orcids":["https://orcid.org/0000-0002-5483-3118"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R Stupp","raw_affiliation_strings":["Multidisciplinary Oncology Center, University Hospital (CHUV), Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Oncology Center, University Hospital (CHUV), Switzerland","institution_ids":["https://openalex.org/I2802229882"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113432586","display_name":"Curzio R\ufffd\ufffdegg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C Regg","raw_affiliation_strings":["University of Lausanne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Lausanne","institution_ids":["https://openalex.org/I97565354"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0143,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.76592325,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"13","issue":"1","first_page":"61","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-grade-glioma","display_name":"high-grade glioma","score":1.0},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/anaplastic-astrocytoma","display_name":"anaplastic astrocytoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9100000262260437},{"id":"https://openalex.org/keywords/carmustine","display_name":"BCNU","score":0.8669999837875366},{"id":"https://openalex.org/keywords/o6-benzylguanine","display_name":"O6-benzylguanine","score":0.9459999799728394},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.9039999842643738},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.5509999990463257},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/recurrent-glioma","display_name":"recurrent glioma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cytotoxic-drugs","display_name":"cytotoxic drugs","score":0.7599999904632568},{"id":"https://openalex.org/keywords/surrogate-markers","display_name":"surrogate markers","score":0.7039999961853027},{"id":"https://openalex.org/keywords/treatment-endpoints","display_name":"treatment endpoints","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.894606351852417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7796893119812012},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.7420845031738281},{"id":"https://openalex.org/C2780147359","wikidata":"https://www.wikidata.org/wiki/Q415869","display_name":"Carmustine","level":4,"score":0.662797749042511},{"id":"https://openalex.org/C2779083369","wikidata":"https://www.wikidata.org/wiki/Q486092","display_name":"Anaplastic astrocytoma","level":4,"score":0.6370382905006409},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6064355969429016},{"id":"https://openalex.org/C2776946711","wikidata":"https://www.wikidata.org/wiki/Q418311","display_name":"Nitrosourea","level":3,"score":0.5241144895553589},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5167436003684998},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.49618086218833923},{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.44858527183532715},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4443942904472351},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.43022823333740234},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42344313859939575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3609251379966736},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.34976649284362793},{"id":"https://openalex.org/C2778880634","wikidata":"https://www.wikidata.org/wiki/Q177755","display_name":"Astrocytoma","level":3,"score":0.25876584649086},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2078152596950531},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.17542949318885803},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.11113551259040833}],"mesh":[],"locations_count":4,"locations":[{"id":"pmid:14732888","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14732888","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Forum (Genoa, Italy)","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unil.ch:iris/245685","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/245685","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:serval.unil.ch:BIB_F2C986804E22","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_F2C986804E22","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Forum, vol. 13, no. 1, pp. 61-75","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:46216662","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14732888","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2078755014","https://openalex.org/W1973710560","https://openalex.org/W2020018735","https://openalex.org/W2157270051","https://openalex.org/W2065497324","https://openalex.org/W254737733","https://openalex.org/W4242718052","https://openalex.org/W4389857460","https://openalex.org/W2096228923","https://openalex.org/W2121205576"],"abstract_inverted_index":{"A":[0],"new":[1,89],"chemotherapy":[2],"agent":[3],"and":[4,76,106,120,131,145,157,178,201],"a":[5,33,81,140,187],"method":[6],"for":[7,16,64,71,116,208],"local":[8],"delivery":[9],"of":[10,19,40,45,80,126,128,147,168,170],"carmustine":[11],"have":[12,60,109,183],"recently":[13,172],"been":[14],"approved":[15,173],"the":[17,23,77,111,135,164,171],"treatment":[18],"malignant":[20,176],"glioma.":[21,101],"However,":[22],"increase":[24],"in":[25,94,97,152,212],"survival":[26],"remains":[27,139],"modest":[28],"at":[29],"best":[30],"with":[31,74,99,118,198],"only":[32],"very":[34],"select":[35],"patients":[36,98,117],"currently":[37,93,136,165],"benefiting":[38],"truly":[39],"these":[41],"treatments.":[42],"Combination":[43,196],"regimen":[44],"different":[46],"alkylating":[47],"agents":[48,91,108,181,200],"or":[49,55],"prior":[50],"O6-alkyltransferase":[51],"depletion":[52],"by":[53],"O6-benzylguanine":[54],"continuous":[56],"temozolomide":[57,73],"administration":[58,127],"schedules":[59],"shown":[61],"some":[62],"indication":[63],"increased":[65],"activity.":[66,190],"There":[67],"is":[68,216],"preclinical":[69],"rational":[70,207],"combining":[72],"radiotherapy":[75],"initial":[78],"results":[79],"phase":[82,114],"II":[83],"clinical":[84,95,112],"trial":[85],"were":[86],"promising.":[87],"Several":[88],"cytotoxic":[90],"are":[92,150,193,204],"trials":[96,215],"recurrent":[100],"More":[102],"importantly,":[103],"targeted":[104],"therapy":[105,203],"antiangiogenic":[107,210],"entered":[110],"development":[113],"also":[115,180],"glioblastoma":[119],"anaplastic":[121],"astrocytoma.":[122],"The":[123,206],"optimal":[124],"timing":[125],"non-cytotoxic":[129],"substances":[130],"their":[132],"integration":[133],"into":[134],"available":[137,166],"treatments":[138],"challenge.":[141],"Novel":[142],"study":[143],"designs":[144],"identification":[146],"surrogate":[148],"markers":[149],"necessary":[151],"order":[153],"to":[154,185],"make":[155],"rapid":[156],"clinically":[158],"meaningful":[159],"progress.":[160],"This":[161],"review":[162],"summarises":[163],"evidence":[167],"activity":[169],"drugs":[174,211],"against":[175],"glioma":[177],"mentions":[179],"which":[182],"failed":[184],"demonstrate":[186],"significant":[188],"antitumour":[189],"Study":[191],"endpoints":[192],"critically":[194],"discussed.":[195,217],"regimens":[197],"other":[199],"radiation":[202],"reviewed.":[205],"using":[209],"selected":[213],"ongoing":[214]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}